Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin

Por Kawai, Akira, Yonemori, Kan, Takahashi, Shunji, Araki, Nobuhito, Ueda, Takafumi
Publicado no Adv Ther (2017)

Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma

Por Ueda, Takafumi, Kakunaga, Shigeki, Ando, Masashi, Yonemori, Kan, Sugiura, Hideshi, Yamada, Kenji, Kawai, Akira
Publicado em 2014

Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report

Por Nagumo, Yoshiyuki, Maejima, Aiko, Toyoshima, Yuta, Komiyama, Motokiyo, Yonemori, Kan, Yoshida, Akihiko, Fujimoto, Hiroyuki
Publicado no Int J Surg Case Rep (2018)

Immunohistochemical Profile for Unknown Primary Adenocarcinoma

Por Hashimoto, Kenji, Sasajima, Yuko, Ando, Masashi, Yonemori, Kan, Hirakawa, Akihiro, Furuta, Koh, Tsuda, Hitoshi, Fujiwara, Yasuhiro
Publicado em 2012

Content Analysis of Oncology-Related Pharmaceutical Advertising in a Peer-Reviewed Medical Journal

Por Yonemori, Kan, Hirakawa, Akihiro, Ando, Masashi, Hirata, Taizo, Yunokawa, Mayu, Shimizu, Chikako, Tamura, Kenji, Fujiwara, Yasuhiro
Publicado em 2012

Use of Cox's Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete...

Por Asano, Junichi, Hirakawa, Akihiro, Hamada, Chikuma, Yonemori, Kan, Hirata, Taizo, Shimizu, Chikako, Tamura, Kenji, Fujiwara, Yasuhiro
Publicado em 2013

Drug induced interstitial lung disease in oncology phase I trials

Por Yonemori, Kan, Hirakawa, Akihiro, Kawachi, Asuka, Kinoshita, Fumie, Okuma, Hitomi, Nishikawa, Tadaaki, Tamura, Kenji, Fujiwara, Yasuhiro, Takebe, Naoko
Publicado no Cancer Sci (2016)

Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study

Por Iizumi, Sakura, Shimomura, Akihiko, Shimoi, Tatsunori, Sudo, Kazuki, Noguchi, Emi, Yonemori, Kan, Shimizu, Chikako, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado no Cancer Chemother Pharmacol (2018)

Primary Yolk Sac Tumor of the Omentum: A Case Report and Literature Review

Por Harano, Kenichi, Ando, Masashi, Sasajima, Yuko, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Tamura, Kenji, Katsumata, Noriyuki, Tsuda, Hitoshi, Fujiwara, Yasuhiro
Publicado em 2012

Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy

Por Tanabe, Yuko, Tsuda, Hitoshi, Yoshida, Masayuki, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Yamamoto, Seiichiro, Kinoshita, Takayuki, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado no Cancer Sci (2017)

Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumors

Por Doi, Toshihiko, Tamura, Kenji, Tanabe, Yuko, Yonemori, Kan, Yoshino, Takayuki, Fuse, Nozomu, Kodaira, Makoto, Bando, Hideaki, Noguchi, Kazuo, Shimamoto, Takashi, Ohtsu, Atsushi
Publicado no Cancer Chemother Pharmacol (2015)

Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose‐finding trials

Por Hirakawa, Akihiro, Yonemori, Kan, Kinoshita, Fumie, Kobayashi, Yumiko, Okuma, Hitomi S., Kawachi, Asuka, Tamura, Kenji, Fujiwara, Yasuhiro, Rubinstein, Larry, Harris, Pamela Jo, Takebe, Naoko
Publicado no Cancer Sci (2017)

Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours

Por Yonemori, Kan, Tamura, Kenji, Kodaira, Makoto, Fujikawa, Koshi, Sagawa, Tamotsu, Esaki, Taito, Shirakawa, Tsuyoshi, Hirai, Fumihiko, Yokoi, Yuki, Kawata, Toshio, Hatano, Ben, Takahashi, Yasuo
Publicado no Cancer Chemother Pharmacol (2016)

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

Por Iizumi, Sakura, Shimoi, Tatsunori, Tsushita, Natsuko, Bun, Seiko, Shimomura, Akihiko, Noguchi, Emi, Kodaira, Makoto, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado no BMC Cancer (2017)

Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy

Por Iizumi, Sakura, Shimoi, Tatsunori, Nishikawa, Tadaaki, Kitano, Atsuko, Sasada, Shinsuke, Shimomura, Akihiko, Noguchi, Emi, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado no Intern Med (2017)

Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site

Por Kodaira, Makoto, Yonemori, Kan, Shimoi, Tatsunori, Yoshida, Akihiko, Yoshida, Masayuki, Kitano, Atsuko, Shimomura, Akihiko, Yunokawa, Mayu, Shimizu, Chikako, Takiguchi, Yuichi, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado no BMC Cancer (2018)

Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents

Por Tanaka, Ryota, Yonemori, Kan, Hirakawa, Akihiro, Kinoshita, Fumie, Takahashi, Naoki, Hashimoto, Jun, Kodaira, Makoto, Yamamoto, Harukaze, Yunokawa, Mayu, Shimizu, Chikako, Fujimoto, Manabu, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado no Oncologist (2016)

Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases

Por OKITA, YOSHIKO, NARITA, YOSHITAKA, SUZUKI, TSUYOSHI, ARITA, HIDEYUKI, YONEMORI, KAN, KINOSHITA, TAKAYUKI, FUJIWARA, YASUHIRO, TSUDA, HITOSHI, KOMOIKE, YOSHIFUMI, NAKAGAWA, HIDEMITSU, TAMAKI, YASUHIRO, TOMITA, YASUHIKO, SHIBUI, SOICHIRO, MARUNO, MOTOHIKO
Publicado em 2013

Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors

Por Tamura, Kenji, Hashimoto, Jun, Tanabe, Yuko, Kodaira, Makoto, Yonemori, Kan, Seto, Takashi, Hirai, Fumihiko, Arita, Shuji, Toyokawa, Gouji, Chen, Lan, Yamamoto, Hiroshi, Kawata, Toshio, Lindemann, Justin, Esaki, Taito
Publicado no Cancer Chemother Pharmacol (2016)

Phase I study of palbociclib, a cyclin‐dependent kinase 4/6 inhibitor, in Japanese patients

Por Tamura, Kenji, Mukai, Hirofumi, Naito, Yoichi, Yonemori, Kan, Kodaira, Makoto, Tanabe, Yuko, Yamamoto, Noboru, Osera, Shozo, Sasaki, Masaoki, Mori, Yuko, Hashigaki, Satoshi, Nagasawa, Takashi, Umeyama, Yoshiko, Yoshino, Takayuki
Publicado no Cancer Sci (2016)